AbbVie Aktie
194,02
EUR
+3,54
EUR
+1,86
%
202,48
USD
+0,34
USD
+0,17
%
nachbörslich
Werbung
AbbVie Aktie Analyse
27.06.19 | AbbVie Peer Perform | Wolfe Research | |
29.04.19 | AbbVie Market Perform | BMO Capital Markets | |
26.12.18 | AbbVie Buy | Standpoint Research | |
02.02.18 | AbbVie Underperform | BMO Capital Markets | |
25.09.17 | AbbVie Neutral | UBS AG | |
15.03.16 | AbbVie Hold | Deutsche Bank AG | |
01.12.15 | AbbVie Equal weight | Barclays Capital | |
23.10.15 | AbbVie Buy | UBS AG | |
Werbung
|
|||
17.04.15 | AbbVie Outperform | BMO Capital Markets | |
06.01.15 | AbbVie Buy | UBS AG | |
26.11.14 | AbbVie Buy | Argus Research Company | |
14.11.14 | AbbVie Buy | Deutsche Bank AG |
Werbung
Werbung